Teresa Monsod Borromeo
Pediatric Endocrinology · Des Moines, IANPI 1326236316
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations.
Across 119 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$400
- Novo Nordisk$375
- Ascendis Pharma Endocrinology Inc$291
- Insulet Corporation$195
- AstraZeneca$126
- Sanofi-aventis U.S. LLC$120
- plus $952 from 23 others
What the payments were for
- Food & beverage$2,44199%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $400 |
| Novo Nordisk | 14 | $375 |
| Ascendis Pharma Endocrinology Inc | 13 | $291 |
| Insulet Corporation | 4 | $195 |
| AstraZeneca | 6 | $126 |
| Sanofi-aventis U.S. LLC | 7 | $120 |
| Pfizer | 6 | $97 |
| Tolmar, Inc. | 5 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| Abbott | 3 | $70 |
| Neurocrine Biosciences, Inc. | 3 | $54 |
| Tolmar Pharmaceuticals, Inc. | 3 | $54 |
| Kyowa Kirin, Inc. | 3 | $54 |
| Biomarin Pharmaceutical Inc. | 3 | $51 |
| Tandem Diabetes Care, Inc. | 3 | $48 |
| Lilly USA, LLC | 3 | $44 |
| Dexcom, Inc. | 2 | $40 |
| BETA Bionics, Inc. | 3 | $38 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| Eton Pharmaceuticals, Inc. | 2 | $35 |
| Ultragenyx Pharmaceutical Inc. | 2 | $28 |
| Medtronic | 1 | $26 |
| Soleno Therapeutics, Inc. | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Rhythm Pharmaceuticals, Inc. | 1 | $17 |
| Endo USA, Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Aegerion Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Norditropin$125
- Omnipod$125
How this compares
Too few pediatric endocrinology providers in Iowato place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Des Moines
- Courtney ReintsDes Moines$174K
- Holly KramerDes Moines$4K
- Erin RichardsonDes Moines$3K
- Maria Parra VillasmilDes Moines$1K
- Jennifer CookDes Moines$231
- Akhila RamakrishnaIowa City$1K
- Michael TanseyIowa City$1K
- Eva TsalikianIowa City$230
- Eirene AlexandrouIowa City$200
- Lauren KannerIowa City$187
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.